Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts

International Journal of Molecular Medicine

Volumn 18, Issue 3, 2006, Pages 497-503

  Inatomi, Osamu ^a   Andoh, Akira ^a   Yagi, Yuhki ^a   Bamba, Shigeki ^a   Tsujikawa, Tomoyuki ^a   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Amphiregulin; Colonic subepithelial myofibroblasts; Epiregulin

Indexed keywords

AMPHIREGULIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIREGULIN; GLYCOPROTEIN; GROWTH PROMOTOR; INTERLEUKIN 1; MESSENGER RNA; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL PROLIFERATION; COLON; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MYOBLAST; SECRETION;

AUTOCRINE COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; COLON; CYTOKINES; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; MYOBLASTS, SMOOTH MUSCLE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750578614     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.3.497     Document Type: Article

References (45)

1. Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137, 2001.
2. Chowdhury A, Fukuda R and Fukumoto S: Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients. J Gastroenterol 31: 353-360, 1996. (Pubitemid 26181790)
3. Tarnawski AS and Jones MK: The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27: 12-20, 1998.
4. Beck PL and Podolsky DK: Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5: 44-60, 1999.
5. Shoyab M, McDonald VL, Bradley JG and Todaro GJ: Amphiregulin: bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci USA 85: 6528-6532, 1988.
6. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ and Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 10: 1969-1981, 1990.
7. Normanno N, Selvam MP, Qi CF, Saeki T, Johnson G, Kim N, Ciardiello F, Shoyab M, Plowman G, Brandt R, Todaro G and Salmon DS: Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proc Natl Acad Sci USA 91: 2790-2794, 1994.
8. Piepkorn M, Lo C and Plowman G: Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J Cell Physiol 159: 114-120, 1994.
9. Chu EK, Foley JS, Cheng J, Patel AS, Drazen JM and Tschumperlin DJ: Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner. Am J Respir Cell Mol Biol 32: 373-380, 2005. (Pubitemid 40629321)
10. Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon DS and Stromberg K: Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol 118: 741-751, 1992.
11. Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS and Coffey RJ Jr: Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer 80: 1012-1019, 1999.
12. Beales IL: Gastrin and interleukin-1beta stimulate growth factor secretion from cultured rabbit gastric parietal cells. Life Sci 75: 2983-2995, 2004.
13. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T and Hanada K: Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development. FEBS Lett 377: 403-407, 1995.
14. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T and Hanada K: Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270: 7495-7500, 1995.
15. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K and Hashimoto K: Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 275: 5748-5753, 2000.
16. Takahashi M, Hayashi K, Yoshida K, Ohkawa Y, Komurasaki T and Kitabatake A: Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells. Circulation 108: 2524-2529, 2003.
17. Lee D, Pearsall RS, Das S, Dey SK, Godfrey VL and Threadgill DW: Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Mol Cell Biol 24: 8907-8916, 2004. (Pubitemid 39313896)
18. Mahida YR, Beltinger J, Makh S, Goke M, Gray T, Podolsky DK and Howkey CJ: Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol 273: 1341-1348, 1997.
19. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI and West AB: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277: 1-9, 1999.
20. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI and West AB: Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277: 183-201, 1999.
21. Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kin-Mitsuyama S, Takayanagi A, Shimizu N and Fujiyama Y: Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984, 2005.
22. Yasui H, Andoh A, Bamba S, Inatomi O, Ishida H and Fujiyama Y: Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts. Digestion 69: 34-44, 2004. (Pubitemid 38332923)
23. Bamba S, Andoh A, Yasui H, Araki Y, Bamba T, and Fujiyama Y: Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 38: 548-554, 2003.
24. Inatomi O, Andoh A, Kitamura K, Yasui H, Zhang Z and Fujiyama Y: Butyrate blocks interferon-gamma-inducible protein- 10 release in human intestinal subepithelial myofibroblasts. J Gastroenterol 40: 483-489, 2005.
25. Andoh A, Bamba S, Fujiyama Y, Brittan M and Wright NA: Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol 40: 1089-1099, 2005.
26. Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H and Bamba T: Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 111: 911-918, 1996.
27. Merlino GT, Ishii S, Whang-Peng J, Knutsen T, Xu YH, Clark AJ, Stratton RH, Wilson RK, Ma DP, Roe BA, Hunts JH, Shimizu N and Pastan I: Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 5: 1722-1734, 1985.
28. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J and Francke U: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985.
29. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ and Shoyab M: Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87: 4905-4909, 1990.
30. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG and Shoyab M: Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90: 1746-1750, 1993.
31. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
32. Toyoda H, Komurasaki T, Uchida D and Morimoto S: Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326: 69-75, 1997. (Pubitemid 27386919)
33. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
34. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Conners RW and Bridges AJ: A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265: 1093-1095, 1994.
35. Shelly M, Pinkas-Kramarski R, Guarino BC, Waterman H, Wang LM, Lyass L, Alimandi M, Kuo A, Bacus SS, Pierce JH, Andrews GC and Yarden Y: Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 273: 10496-10505, 1998.
36. Kansra S, Stoll SW, Johnson JL and Elder JT: Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK. Mol Biol Cell 15: 4299-4309, 2004.
37. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP and Raedler A: Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181, 1993.
38. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujimiya M, and Bamba T: Interleukin-1β, and Tumor Necrosis Factor-α induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 37: 317-324, 2002.
39. Jobson TM, Billington CK and Hall IP: Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. J Clin Invest 101: 2650-2657, 1998.
40. Heitz PU, Kasper M, van Noorden S, Polak JM, Gregory H and Pearse AG: Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands. Gut 19: 408-413, 1978.
41. Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, Patel A, French S and Eysselein VE: Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 107: 12-17, 1994.
42. Sinha A, Nightingale J, West KP, Berlanga-Acosta J and Playford RJ: Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349: 350-357, 2003.
43. Murthy S, Mathur SN and Field FJ: Tumor necrosis factor-alpha and interleukin-1beta inhibit apolipoprotein B secretion in CaCo-2 cells via the epidermal growth factor receptor signaling pathway. J Biol Chem 275: 9222-9229, 2000.
44. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, Fukuyama K, Yamamoto K, Mekada E and Sasazuki T: Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res 60: 6886-6889, 2000.
45. Egger B, Procaccino F, Lakshmanan J, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, Patel A, French S and Eysselein VE: Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 113: 825-832, 1997.